SEC 13F Intelligence

Stephens Investment Management Group LLC / DXCM

Stephens Investment Management Group LLC’s Dexcom Inc Position

Does Stephens Investment Management Group LLC own Dexcom Inc (DXCM)? Yes — 1.07M shares worth $67M (+0.92% of its 13F portfolio) as of Q1 2026, up from 1.04M shares the prior filed quarter.

Position Value
$67M
Q1 2026
Shares
1.07M
% of Portfolio
+0.92%
Quarters Held
30
currently held

Position History DXCM

Reported value by quarter
Q4 ’18: $35MQ4 ’18Q1 ’19: $33MQ2 ’19: $44MQ3 ’19: $45MQ4 ’19: $62MQ4 ’19Q1 ’20: $72MQ2 ’20: $88MQ3 ’20: $79MQ4 ’20: $65MQ4 ’20Q1 ’21: $65MQ2 ’21: $76MQ3 ’21: $95MQ4 ’21: $76MQ4 ’21Q1 ’22: $74MQ2 ’22: $43MQ3 ’22: $49MQ4 ’22: $69MQ4 ’22Q1 ’23: $71MQ2 ’23: $80MQ3 ’23: $59MQ4 ’23: $78MQ4 ’23Q1 ’24: $87MQ2 ’24: $75MQ3 ’24: $46MQ4 ’24: $55MQ4 ’24Q1 ’25: $57MQ2 ’25: $77MQ3 ’25: $58MQ4 ’25: $69MQ4 ’25Q1 ’26: $67Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.07M$67M+0.92%
Q4 20251.04M$69M+0.90%
Q3 2025861.1K$58M+0.75%
Q2 2025877.8K$77M+1.01%
Q1 2025841.1K$57M+0.83%
Q4 2024703.9K$55M+0.73%
Q3 2024684.5K$46M+0.63%
Q2 2024665.2K$75M+1.06%
Q1 2024629.6K$87M+1.16%
Q4 2023625.9K$78M+1.14%
Q3 2023630.6K$59M+0.97%
Q2 2023622.7K$80M+1.25%
Q1 2023613.9K$71M+1.19%
Q4 2022613.3K$69M+1.25%
Q3 2022611.8K$49M+0.93%
Q2 2022576.2K$43M+0.79%
Q1 2022144.4K$74M+1.08%
Q4 2021141.7K$76M+0.98%
Q3 2021172.8K$95M+1.29%
Q2 2021178.5K$76M+1.04%
Q1 2021180.0K$65M+0.94%
Q4 2020176.7K$65M+0.97%
Q3 2020192.7K$79M+1.41%
Q2 2020216.8K$88M+1.59%
Q1 2020265.8K$72M+1.73%
Q4 2019283.6K$62M+1.17%
Q3 2019298.3K$45M+0.89%
Q2 2019290.4K$44M+0.82%
Q1 2019275.3K$33M+0.67%
Q4 2018290.4K$35M+0.82%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Stephens Investment Management Group LLC’s full portfolio or all institutional holders of DXCM.